Mohamed A. Kharfan-Dabaja, M.D., M.B.A.

Image 1 | Mohamed A. Kharfan-Dabaja, M.D., M.B.A. Image 2 | Mohamed A. Kharfan-Dabaja, M.D., M.B.A.
Yext tracking pixel

Mohamed Kharfan-Dabaja, MD, MBA, is a hematologist and oncologist at Mayo Clinic Comprehensive Cancer Center in Jacksonville, Florida. Dr. Kharfan-Dabaja treats cancers including acute myelogenous leukemia, chronic lymphocytic leukemia, diffuse large b-cell lymphoma, Hodgkin lymphoma and non-Hodgkin’s lymphoma. He is an expert in chimeric antigen receptor T-cell therapy (CAR T-cell therapy) and bone marrow transplant, with special interest in CAR T-cell therapy for lymphoid neoplasms and reduced intensity allogeneic hematopoietic cell transplantation for hematologic malignancies.

Dr. Kharfan-Dabaja is Vice-Chair of Hematology, Director of the Blood and Marrow Transplantation and Clinical Cellular Immune Therapies Program, and Associate Medical Director for the Cancer Clinical Trials Office at Mayo Clinic in Florida. Mayo Clinic Comprehensive Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer center.

Monday: 8:00am to 5:00pm
Tuesday: 8:00am to 5:00pm
Wednesday: 8:00am to 5:00pm
Thursday: 8:00am to 5:00pm
Friday: 8:00am to 5:00pm

Languages: English, Spanish, Arabic

Tags: CAR-T Cell Therapy, Multiple Myeloma, Acute Lymphoblastic Leukemia, Stem Cell Transplant, Mantle Cell Lymphoma, White Blood Cell, Blood Cancers, Car T Cell Therapy Process, Car T Cell Therapy Death Rate, what happens if car t-cell therapy fails, what is car t cell therapy, car t cell therapy cost, car t cell therapy side effects, car t therapy jacksonville, car t therapy jacksonville fl, car t cell therapy for leukemia, car t cell therapy for lymphoma, car t cell therapy for multiple myeloma, car t cell therapy success rate, where is car t cell therapy available, what cancers can be treated with car t cell therapy

Reviews


No reviews yet. Be the first to write a review!